$NNOX

Daniel Ran sold (to issuer) $890 of NNOX

Daniel Ran (CFO) sold (to issuer) 1,000 shares of Nano-X Imaging Ltd. (NNOX) at $0.89 on 2026-07-29.

Original reporting
SEC EDGAR · Daniel Ran
Published Jul 29, 2026, 11:01 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 11:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NNOX
Neutral
low confidence
Mentioned
$NNOX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NNOXNeutralLow
01

Why it matters

This provides a fresh datapoint on insider activity (CFO Daniel Ran sold 1,000 shares to the issuer at $0.8900/share) but does not disclose new company fundamentals.

02

Market read

Traders may note insider selling, but the disclosed value is small and the filing contains no new guidance or operational catalyst.

03

What to watch

The transaction size is very small ($890) and there is no accompanying narrative about earnings, guidance, or business developments, limiting tradable signal strength.

Relevance 3/10Novelty 2/10Timing: filed 2026-07-29 (same day as transaction)

Background

The article is an SEC Form 4 insider transaction disclosure for Nano-X Imaging Ltd. (NNOX).

Company-level read

Ticker impact

$NNOXNeutralLow confidence
Context

SEC Form 4 shows CFO Daniel Ran sold 1,000 shares to the issuer at $0.8900/share on 2026-07-29.

Expected impact

Likely minimal near-term price impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction with modest dollar value ($890) and no 10b5-1 plan disclosed, but the transaction type is sale to issuer (often buyback-related) and lacks any new operating or guidance information.

Market effects

No sector read-across; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Because the sale is to the issuer, it may be tied to a company buyback or administrative mechanism rather than a bearish view on fundamentals.

Key entities

  • Nano-X Imaging Ltd.

    Subject of the Form 4 insider transaction disclosure.

  • Daniel Ran

    CFO of Nano-X Imaging Ltd., reported sale to issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NNOXMed

NANO-X IMAGING LTD: Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Nanox Imaging Ltd (NASDAQ: NNOX) said its subsidiary Nanox AI entered an exclusive UK sales reseller agreement with Vertec Scientific for commercialization of Nanox.AI bone solution (HealthOST). The initial three-year term requires Vertec to meet minimum annual license commitments. HealthOST is FDA-cleared and UKCA/CE-marked and was recommended by NICE in Nov 2025 for NHS use.